Myriad Genetics Inc (LTS:0K3W)
$ 13.635 0.293 (2.19%) Market Cap: 1.24 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 1.70 GF Score: 63/100

Myriad Genetics Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 06:20PM GMT
Release Date Price: $23.39
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Welcome to Bank of America's 2022 Healthcare Conference live from Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostic tools analyst. And our next company is Myriad Genetics. And with us from Myriad is Paul Diaz, President and CEO. Paul, welcome. Thanks for being here.

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Great to be here. Thanks for the invitation.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So Paul just to -- you're 2 years into the CEO role?

Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director

Not quite.

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Not quite 2 years in, yes. And I first picked up coverage of Myriad in 2001, right? So I've got -- been looking at this going to be a long time. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot